ozanimod



ozanimod


SMILES CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@@H]4NCCO)no2)cc1C#N
InChIKey XRVDGNKRPOAQTN-FQEVSTJZSA-N

Chemical Properties

Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 7
Molecular weight (Da) 404.2


No bioactivity data available.

ozanimod


Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I
Phase II
Phase III
Phase IV


Compound is not listed as a drug.